The Effect of Su-Jok Application and Progressive Muscle Relaxation Exercises in Coping With Premenstrual Syndrome
1 other identifier
interventional
135
1 country
1
Brief Summary
The aim of this study is to determine the effect of su-jok application and progressive muscle relaxation exercise in coping with premenstrual syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2024
CompletedFirst Posted
Study publicly available on registry
March 6, 2024
CompletedStudy Start
First participant enrolled
April 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2024
CompletedJune 7, 2024
February 1, 2024
3 months
February 12, 2024
June 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
PAIN Visual Analog Scale (VAS)- (Min:0 - Max:10)
In the 1st, 2nd and 3rd month menstrual periods; * Premenstrual Syndrome Scale * VAS evaluation scale will be applied.
3 months
FATIGUE Visual Analog Scale (VAS)- (Min:0 - Max:10)
In the 1st, 2nd and 3rd month menstrual periods; * Premenstrual Syndrome Scale * VAS evaluation scale will be applied.
3 months
SLEEP STATE Visual Analog Scale (VAS)- (Min:0 - Max:10)
In the 1st, 2nd and 3rd month menstrual periods; * Premenstrual Syndrome Scale * VAS evaluation scale will be applied.
3 months
NAUSEA VOMITING Visual Analog Scale (VAS)- (Min:0 - Max:10)
In the 1st, 2nd and 3rd month menstrual periods; * Premenstrual Syndrome Scale * VAS evaluation scale will be applied.
3 months
Change in Premenstrual Symptoms (People with PMS scale scores over 104 points will be determined).
In the 1st, 2nd and 3rd month menstrual periods; * Premenstrual Syndrome Scale * VAS evaluation scale will be applied.
3 months
Study Arms (3)
Progressive Muscle Relaxation Exercise Group
EXPERIMENTALApplication will be made on the day PMS symptoms begin and throughout the menstrual cycle.
Su-Jok Group
EXPERIMENTALApplication will be made on the day PMS symptoms begin and throughout the menstrual cycle.
Control Group
NO INTERVENTIONNo application will be made to this group by the researcher.
Interventions
Exercise Group
Eligibility Criteria
You may qualify if:
- Getting over 104 points from the PMS scale,
- Having regular menstruation,
- Not having any chronic disease,
- Not using any method to cope with PMS.
You may not qualify if:
- Having irregular menstruation,
- Having musculoskeletal system and respiratory diseases,
- Having a diagnosed psychiatric disease,
- Having a disease that may cause premenstrual symptoms and receiving medical treatment (thyroid diseases, heart failure, neurological disorders)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sağlık Bilimleri Üniversitesi
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Filiz Ünal Toprak, PhD
Saglik Bilimleri Universitesi
- PRINCIPAL INVESTIGATOR
Sevil Albayrak, PhD
Kıbrıs İlim Üniversitesi
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Double (Participant, Outcomes Assessor) Since the application will be performed by the researcher, participant will be blinded in this study. The statistician will be blinded in the evaluation of the data.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2024
First Posted
March 6, 2024
Study Start
April 10, 2024
Primary Completion
July 15, 2024
Study Completion
August 15, 2024
Last Updated
June 7, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share